Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Angion's CYP11B2 inhibitor shows potential for CKD in animal models

Nov. 25, 2015

FDA grants orphan drug designation to Amyndas Pharmaceuticals' Compstatin 40

Nov. 18, 2015

ProMetic reveals agent under development for diabetic nephropathy

Nov. 18, 2015

Sophiris Bio reports results from phase III trial of PRX-302 in BPH

Nov. 13, 2015

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Nov. 9, 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Nov. 9, 2015

Preclinical toxicity study results for Pyridorin will support planned IND filing

Nov. 9, 2015

Quark Pharmaceuticals plans new trials of QPI-1002

Nov. 3, 2015

Isis Pharmaceuticals begins phase II study of ISIS-FXIRx in end-stage renal disease

Nov. 3, 2015

Taiho starts phase I trial of TAS-303 in women with stress urinary incontinence

Nov. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...